Bell's Palsy, an Adverse Event Following COVID Vaccines.

Q3 Medicine
Maheen Pyarali, Maira Adeel, Ahmad Nawaz, Saher Uneeb, Ayesha-Bibi Fazal Dad, Saniya Amir
{"title":"Bell's Palsy, an Adverse Event Following COVID Vaccines.","authors":"Maheen Pyarali, Maira Adeel, Ahmad Nawaz, Saher Uneeb, Ayesha-Bibi Fazal Dad, Saniya Amir","doi":"10.22038/IJORL.2024.69721.3364","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Bell's palsy is one of the most concerning complications of the COVID vaccine that has impacted vaccine acceptance among the general population. These vaccines were introduced to provide immunity against the SARS-CoV-2 coronavirus and have been found to be quite effective. Little did we know that Bell's palsy could be one of its serious complications.</p><p><strong>Materials and methods: </strong>We used various search engines to gather data in the form of a case series and case reports related to patients who were affected by the vaccine and had developed Bell's palsy.</p><p><strong>Results: </strong>A total of eleven case reports and 4 case series were included in the analysis. The vaccines mentioned in the case reports were Pfizer, Moderna, Sinovac, AstraZeneca, and Janssen, while the case series included Pfizer and Sinovac. The majority of patients were female and aged between 31-40 years. Right-sided laterality was observed in 45.45% of patients, left-sided laterality in 45.45% of patients, and bilateral laterality in 9.1% of patients. Three patients had a history of Bell's palsy or stroke. After treatment, three patients showed partial improvement, six patients fully recovered, and the status of two patients was unknown.</p><p><strong>Conclusions: </strong>Bell's palsy is a rare complication that can occur after receiving the COVID-19 vaccine. This review aims to increase awareness about this rare adverse event of the vaccine so that it can be properly addressed and managed. Additionally, it will serve as a foundation for future research on the administration of the COVID-19 vaccine.</p>","PeriodicalId":14607,"journal":{"name":"Iranian Journal of Otorhinolaryngology","volume":"36 4","pages":"527-535"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247443/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Otorhinolaryngology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22038/IJORL.2024.69721.3364","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Bell's palsy is one of the most concerning complications of the COVID vaccine that has impacted vaccine acceptance among the general population. These vaccines were introduced to provide immunity against the SARS-CoV-2 coronavirus and have been found to be quite effective. Little did we know that Bell's palsy could be one of its serious complications.

Materials and methods: We used various search engines to gather data in the form of a case series and case reports related to patients who were affected by the vaccine and had developed Bell's palsy.

Results: A total of eleven case reports and 4 case series were included in the analysis. The vaccines mentioned in the case reports were Pfizer, Moderna, Sinovac, AstraZeneca, and Janssen, while the case series included Pfizer and Sinovac. The majority of patients were female and aged between 31-40 years. Right-sided laterality was observed in 45.45% of patients, left-sided laterality in 45.45% of patients, and bilateral laterality in 9.1% of patients. Three patients had a history of Bell's palsy or stroke. After treatment, three patients showed partial improvement, six patients fully recovered, and the status of two patients was unknown.

Conclusions: Bell's palsy is a rare complication that can occur after receiving the COVID-19 vaccine. This review aims to increase awareness about this rare adverse event of the vaccine so that it can be properly addressed and managed. Additionally, it will serve as a foundation for future research on the administration of the COVID-19 vaccine.

COVID疫苗不良反应--贝尔氏麻痹。
简介:贝尔麻痹是 COVID 疫苗最令人担忧的并发症之一,影响了普通人群对疫苗的接受程度。这些疫苗的引入是为了提供对 SARS-CoV-2 冠状病毒的免疫力,并且被认为相当有效。我们很少知道贝尔麻痹可能是其严重并发症之一:我们使用了各种搜索引擎,以病例系列和病例报告的形式收集受疫苗影响并出现贝尔氏麻痹的患者的相关数据:共有 11 个病例报告和 4 个系列病例被纳入分析。病例报告中提到的疫苗包括辉瑞、Moderna、Sinovac、阿斯利康和杨森,而系列病例包括辉瑞和Sinovac。大多数患者为女性,年龄在 31-40 岁之间。45.45%的患者为右侧侧位,45.45%的患者为左侧侧位,9.1%的患者为双侧侧位。三名患者曾有贝尔氏麻痹或中风病史。治疗后,3 名患者病情部分好转,6 名患者完全康复,2 名患者病情不明:贝尔氏麻痹是一种罕见的并发症,在接种 COVID-19 疫苗后可能会发生。本综述旨在提高人们对这一罕见疫苗不良事件的认识,以便妥善处理和控制。此外,它还将为今后有关 COVID-19 疫苗接种的研究奠定基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Iranian Journal of Otorhinolaryngology
Iranian Journal of Otorhinolaryngology Medicine-Otorhinolaryngology
CiteScore
1.30
自引率
0.00%
发文量
72
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信